SK Life Science, Inc. uses modern cloud
solution to accelerate validation processes for increased
inspection readiness
BARCELONA, Spain, Jan. 11, 2024 /PRNewswire/ -- Veeva Systems
(NYSE: VEEV) today announced that SK Life Science, Inc., a
subsidiary of SK Biopharmaceuticals Co. Ltd., a global biotech
company, is using Veeva Vault Validation Management to streamline
and accelerate their validation process. By adopting a validation
solution with built-in best practices, the company can execute
digital validation while centralizing data and improving
visibility.
"As the industry continues to shift from traditional paper-based
validation, more companies are advancing validation with Veeva
Vault Validation Management to streamline and standardize
processes," said Nina Ricciardelli,
director, Veeva Vault Validation Management. "SK Life Science, Inc.
is a prime example of one of those forward-thinking companies
modernizing validation for greater efficiency and speed."
SK Life Science, Inc., an innovative pharmaceutical company
committed to accelerating the development of next-generation
treatments for central nervous system (CNS) disorders and cancer
care, adopted Vault Validation Management to further support its
team with digital collaboration, standardized processes and
workflows, and simpler test execution. The company is building off
its success with Veeva Vault QualityDocs and Veeva Vault QMS to
optimize its validation programs, driving greater compliance and
traceability across all systems. Shifting to a digital approach
provides the transparency necessary to identify trends and
proactively address potential issues, reducing compliance
risks.
"Veeva Vault Validation Management allows us to further simplify
our validation process for significant cost and time-savings in
test execution," said Hina Patel,
vice president and global head of quality assurance, SK Life
Science, Inc. "Using an advanced validation solution helps improve
our efficiency, data integrity, and audit readiness."
Additional Information
For more on Veeva Vault
Validation Management, visit:
veeva.com/eu/VaultValidationManagement Connect with Veeva on
LinkedIn: linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information, visit
veeva.com/eu.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10-Q for the period ended October 31, 2023, which you can
find here (a summary of risks which may impact our
business can be found on pages 38 and 39), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
|
|
Jeremy Whittaker
Veeva Systems
+49-695-095-5486
jeremy.whittaker@veeva.com
|
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
|
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/leading-pharma-adopts-veeva-vault-validation-management-for-digital-validation-execution-and-improved-efficiency-302031721.html